SUBSCRIBERS

Teva's generic version of AstraZeneca's Nexium gets FDA nod

Published Tue, Jan 27, 2015 · 09:50 PM

New York

THE US Food and Drug Administration said it approved Teva Pharmaceutical Industries Ltd's generic version of AstraZeneca Plc's blockbuster heartburn drug Nexium, the agency's first such approval for the drug.

The approval comes as generic drugmakers scramble to get their versions to the market and AstraZeneca is taken to court over so-called "pay-for-d…

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes

Consumer & Healthcare

Sony deal for Paramount would draw added regulatory scrutiny
Lululemon to shutter Washington distribution center, lay off 128 employees
Gazelle Ventures makes cash offer for No Signboard shares at S$0.0021 apiece
P&G raises annual core profit forecast on resilient demand, price hikes
Cordlife calls for trading halt after shares sink to all-time low, pending announcement
Marina Bay Sands Q1 profit surges 51.5% to US$597 million on tourism boom

Companies & Markets

Teva's generic version of AstraZeneca's Nexium gets FDA nod

Consumer & Healthcare

Sony deal for Paramount would draw added regulatory scrutiny

Lululemon to shutter Washington distribution center, lay off 128 employees

Gazelle Ventures makes cash offer for No Signboard shares at S$0.0021 apiece

P&G raises annual core profit forecast on resilient demand, price hikes

Cordlife calls for trading halt after shares sink to all-time low, pending announcement

Marina Bay Sands Q1 profit surges 51.5% to US$597 million on tourism boom

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

SECTIONS

LIFESTYLE

Follow BT